A well-established approach for the estimation of insulin secretion in vivo is based on the measurement of plasma C-peptide. C-peptide is secreted by pancreatic ␤-cells in equimolar amounts with insulin, but unlike insulin, C-peptide is not extracted by the liver and has a constant peripheral clearance. Thus, the systemic (venous) appearance of C-peptide equals the pancreatic release of insulin. The C-peptide systemic appearance can be calculated by deconvolution from the plasma C-peptide concentrations and a kinetic model of C-peptide distribution (1). This method has been used to evaluate 24-h profiles of insulin secretion (2) and the ␤-cell dose-response curve (3).
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We developed a model for assessing the 24-h profile of insulin secretion and its control by glucose, simultaneously. To date, the model has been tested in lean and obese nondiabetic subjects.
RESEARCH DESIGN AND METHODS
A total of 20 obese subjects (BMI 50 ± 2 kg/m 2 ) and 7 nonobese (BMI 27 ± 1 kg/m 2 ) age-and sex-matched control subjects spent 24 h in a calorimetric chamber under standardized conditions of diet and physical activity. Four meals were administered for a total caloric intake of 30 kcal per kg of lean body mass (20% breakfast, 40% lunch, 10% afternoon snack, and 30% dinner). The diet consisted of 17% protein, 35% fat, and 48% carbohydrate. In each subject, central venous blood (for measurement of glucose, insulin, and C-peptide) was sampled hourly through an indwelling catheter, which was derived externally via an airtight port of the chamber. Insulin secretion rates (ISR) were reconstructed from C-peptide levels by deconvolution and related to concomitant glucose levels by a mathematical model.
The model ( Fig. 1 ) consisted of three submodels: a submodel for fitting glucose concentrations, a submodel for C-peptide kinetics, and a submodel for relating insulin secretion to glucose concentration. The glucose submodel was used to obtain a glucose concentration profile continuous in time, which could also allow the calculation of the time derivative of glucose concentration.
The insulin secretion submodel is composed of three terms. The first term, S = p 3 ln(p 1 + e G+p2/p3 , expresses a static dependence of insulin secretion on glucose concentration. This submodel provides the ␤-cell dose-response function. From this function, an index of ␤-cell sensitivity can be obtained as the insulin secretion at a target glucose level G t . The second term, p 4 G · (t), expresses a dynamic dependence of insulin secretion on the rate of change of glucose concentration (4). The parameter p 4 is, thus, the sensitivity of the ␤-cell to the glucose concentration changes. The third term, the residual insulin secretion term, S r (t), takes into consideration the fact that glucose levels cannot fully account for the observed insulin secretion, i.e., insulin secretion may also depend on other secretagogues or may have a random component. The C-peptide kinetics submodel is based on a twoexponential representation of the C-peptide impulse response h(t). Because the identification of the C-peptide impulse response in an individual subject requires additional kinetic experiments with biosynthetic C-peptide (1), h(t) has been determined in each subject from anthropometric data, according to the approach developed by Van Cauter et al.
(5). C-peptide concentration [C(t)] is the convolution between the two-exponential h(t) and C-peptide secretion: C(t) = h(t) ᮏ S(t).

RESULTS
Insulin secretion and its components are shown in Fig. 2 . The four secretory peaks corresponding to the meals are clearly visible. Approximately 80% of insulin secretion could be related to glucose levels in a functional form (the first two terms of the insulin secretion submodel), whereas the remainder was accounted for by the residual term S r (t). The term p 4 G · (t) was generally small. The residual term S r (t) was variable among subjects. The range of the standard deviation of S r (t) was 41-319 pmol/min. The time course of S r (t) indicates that insulin secretion was lower during the night compared with during the day, even after accounting for the lower glucose levels, suggesting that insulin secretion may follow an inherent circadian pattern. The presence of secondary peaks in S r (t), which bear some relation to the main peaks of insulin secretion, may indicate the existence of secretory features not included in the model. Diurnal ISR was 75 ± 8 vs. 36 ± 3 U (P = 0.007 obese subjects vs. control subjects), whereas nocturnal ISR was 11 ± 1 vs. 4 ± 1 U (P = 0.002). The diurnal-to-nocturnal ISR ratio is 6.8 ± 0.3 vs. 9.0 ± 1.0. The average ␤-cell dose-response functions are shown in Fig. 3 for the obese subjects and the control subjects. The ␤-cell sensitivity index represented by insulin secretion at 8 mmol/l glucose concentration was correlated with the parameter representing the sensitivity of the ␤-cell to the glucose rate of change, p 4 (R = 0.84, P < 0.0001). This indicates that both of these ␤-cell sensitivity indexes reflect pancreatic function, despite the fact that the insulin secretion component was small, due to the glucose rate of change. Clearly, the dose-response curve for the obese subjects is shifted to the left and upwards of that for the control subjects, but the secretory response to the highest observed glucose level (10 mmol/l) was similar between the two groups. The model indicated that in the obese group, whereas ISR at basal glucose (4 mmol/l) was strongly enhanced (317 ± 38 vs. 91 ± 32 pmol/min, P = 0.002), ␤-cell glucose sensitivity was actually depressed (160 ± 40 vs. 1,393 ± 495, P = 0.0002). In the entire database, insulin secretion at 4 mmol/l glucose (i.e., basal insulin secretion) was directly related to the mean 24-h plasma concentration of free fatty acids, suggesting a role for this substrate in the tonic maintenance of basal insulin production. 
